The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth ...

A drug used to prevent the rejection of transplanted organs and as an experimental cancer treatment in humans can significantly increase lifespan when given to adult mice, researchers have found. Mice ...

In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, ...

BHT-3021 is not the only therapy in the T1D drug pipeline that aims to promote immune tolerance. The monoclonal antibodies (mAbs) otelixizumab (Tolerx/GlaxoSmithKline) and teplizumab (MacroGenics ...

Immune checkpoints are like a brake on the human ... With the experimental doublet immunotherapy drug combination, data show a promising 94% overall survival rate at two years, warranting further ...

This will be done by generating drugs that can easily cross into the brain to block this activity. Antibodies are produced by our immune systems in response to foreign substances, such as viruses or ...

Sanofi agreed to pay $600 million for a therapy in early human testing that may have the ability to “reset” a patient’s immune system and ward off debilitating inflammatory diseases.

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...